Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Aversa

Showing results (91-100 of 160) with videos related to

Pageof 16
Sort By:
Blood Cells, Molecules & Diseases|October 13, 2007
Large-scale generation of human allodepleted anti-3rd party lymphocytesMaria De Ioanni, Mauro Di Ianni, Elisabetta Bonifacio, et al.
International Journal of Radiation Oncology, Biology, Physics|September 14, 2016
The Total Body Irradiation Schedule Affects Acute Leukemia Relapse After Matched T Cell-Depleted Hematopoietic Stem Cell TransplantationCynthia Aristei, Alessandra Carotti, Elisa Palazzari, et al.
The Journal of Infection|August 7, 2017
Estimated burden of fungal infections in ItalyMatteo Bassetti, Alessia Carnelutti, Maddalena Peghin, et al.
Plos One|December 2, 2011
The C allele of rs5743836 polymorphism in the human TLR9 promoter links IL-6 and TLR9 up-regulation and confers increased B-cell proliferationAgostinho Carvalho, Nuno S Osório, Margarida Saraiva, et al.
Leukemia|March 24, 2018
The -2518 A/G polymorphism of the monocyte chemoattractant protein-1 as a candidate genetic predisposition factor for secondary myelofibrosis and biomarker of disease severityElena Masselli, Cecilia Carubbi, Benedetta Cambò, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLCGiulia Mazzaschi, Francesco Facchinetti, Gabriele Missale, et al.
British Journal of Haematology|November 17, 2017
Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myelomaBenedetta Dalla Palma, Valentina Marchica, Mario Pedrazzoni, et al.
Haematologica|May 14, 2011
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart ProjectLivio Pagano, Morena Caira, Annamaria Nosari, et al.
Blood|December 31, 2009
Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant groupThomas Klingebiel, Jacqueline Cornish, Myriam Labopin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 10, 2015
The Proteasome Inhibitor Bortezomib Maintains Osteocyte Viability in Multiple Myeloma Patients by Reducing Both Apoptosis and Autophagy: A New Function for Proteasome InhibitorsDenise Toscani, Carla Palumbo, Benedetta Dalla Palma, et al.
Pageof 16

Showing results (91-100 of 160) with videos related to

Sort By:
Pageof 16
Blood Cells, Molecules & Diseases|October 13, 2007
Large-scale generation of human allodepleted anti-3rd party lymphocytesMaria De Ioanni, Mauro Di Ianni, Elisabetta Bonifacio, et al.
International Journal of Radiation Oncology, Biology, Physics|September 14, 2016
The Total Body Irradiation Schedule Affects Acute Leukemia Relapse After Matched T Cell-Depleted Hematopoietic Stem Cell TransplantationCynthia Aristei, Alessandra Carotti, Elisa Palazzari, et al.
The Journal of Infection|August 7, 2017
Estimated burden of fungal infections in ItalyMatteo Bassetti, Alessia Carnelutti, Maddalena Peghin, et al.
Plos One|December 2, 2011
The C allele of rs5743836 polymorphism in the human TLR9 promoter links IL-6 and TLR9 up-regulation and confers increased B-cell proliferationAgostinho Carvalho, Nuno S Osório, Margarida Saraiva, et al.
Leukemia|March 24, 2018
The -2518 A/G polymorphism of the monocyte chemoattractant protein-1 as a candidate genetic predisposition factor for secondary myelofibrosis and biomarker of disease severityElena Masselli, Cecilia Carubbi, Benedetta Cambò, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLCGiulia Mazzaschi, Francesco Facchinetti, Gabriele Missale, et al.
British Journal of Haematology|November 17, 2017
Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myelomaBenedetta Dalla Palma, Valentina Marchica, Mario Pedrazzoni, et al.
Haematologica|May 14, 2011
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart ProjectLivio Pagano, Morena Caira, Annamaria Nosari, et al.
Blood|December 31, 2009
Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant groupThomas Klingebiel, Jacqueline Cornish, Myriam Labopin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 10, 2015
The Proteasome Inhibitor Bortezomib Maintains Osteocyte Viability in Multiple Myeloma Patients by Reducing Both Apoptosis and Autophagy: A New Function for Proteasome InhibitorsDenise Toscani, Carla Palumbo, Benedetta Dalla Palma, et al.
Pageof 16